BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10568636)

  • 1. Ticlopidine and TTP after coronary stenting.
    McCullough PA; Marks KR
    JAMA; 1999 Nov; 282(18):1717-8; author reply 1718-9. PubMed ID: 10568636
    [No Abstract]   [Full Text] [Related]  

  • 2. Ticlopidine and TTP after coronary stenting.
    Bennett CL; Davidson CJ; Green D; Weinberg PD; Feldman MD
    JAMA; 1999 Nov; 282(18):1717; author reply 1718-9. PubMed ID: 10568635
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombotic thrombocytopenic purpura after stenting and ticlopidine.
    Bennett CL; Kiss JE; Weinberg PD; Pinevich AJ; Green D; Kwaan HC; Feldman MD
    Lancet; 1998 Sep; 352(9133):1036-7. PubMed ID: 9759754
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute renal failure and thrombocytopenia after ticlopidine--not necessarily thrombotic thrombocytopenic purpura.
    Sannes MR; Modi KS
    Nephrol Dial Transplant; 2000 Jul; 15(7):1076-9. PubMed ID: 10862654
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.
    Steinhubl SR; Tan WA; Foody JM; Topol EJ
    JAMA; 1999 Mar; 281(9):806-10. PubMed ID: 10071001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic thrombocytopenic purpura: a rare but potential life-threatening complication following ticlopidine administration.
    Jamar S; Vanderheyden M; Janssens L; Hermans L; Jamar R; Verstreken G
    Acta Cardiol; 1998; 53(5):285-6. PubMed ID: 9922807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention.
    Bennett CL; Davidson CJ; Raisch DW; Weinberg PD; Bennett RH; Feldman MD
    Arch Intern Med; 1999 Nov; 159(21):2524-8. PubMed ID: 10573042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticlopidine and thrombotic thrombocytopenic purpura.
    Kupfer Y; Tessler S
    N Engl J Med; 1997 Oct; 337(17):1245. PubMed ID: 9340529
    [No Abstract]   [Full Text] [Related]  

  • 9. Absence of thrombotic thrombocytopenic purpura following coronary stenting in the ticlopidine era.
    Brown DL
    Am J Cardiol; 1999 Feb; 83(4):640-1. PubMed ID: 10073887
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse events. Data from the Evaluation of Platelets IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial].
    De Servi S
    Ital Heart J Suppl; 2001 Jul; 2(7):805-6. PubMed ID: 11508303
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatal neutropenia and thrombocytopenia associated with ticlopidine after stenting.
    Szto GY; Linnemeier TJ; Ball MW
    Am J Cardiol; 1999 Jan; 83(1):138-9, A10. PubMed ID: 10073806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after coronary artery stenting.
    Manor SM; Guillory GS; Jain SP
    Pharmacotherapy; 2004 May; 24(5):664-7. PubMed ID: 15162901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel and thrombotic thrombocytopenic purpura.
    Hankey GJ
    Lancet; 2000 Jul; 356(9226):269-70. PubMed ID: 11071178
    [No Abstract]   [Full Text] [Related]  

  • 14. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel-induced hepatotoxicity after percutaneous coronary stenting.
    Chau TN; Yim KF; Mok NS; Chan WK; Leung VK; Leung MF; Lai ST
    Hong Kong Med J; 2005 Oct; 11(5):414-6. PubMed ID: 16219965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The ISAR-SAFE study].
    Capranzano P; Castiglioni B
    G Ital Cardiol (Rome); 2015 Jun; 16(6):331-5. PubMed ID: 26156693
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombotic thrombocytopenic purpura associated with ticlopidine use: a report of 3 cases and review of the literature.
    Chen DK; Kim JS; Sutton DM
    Arch Intern Med; 1999 Feb; 159(3):311-4. PubMed ID: 9989544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticlopidine-carbamazepine interaction in a coronary stent patient.
    Brown RI; Cooper TG
    Can J Cardiol; 1997 Sep; 13(9):853-4. PubMed ID: 9343036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel and thrombotic thrombocytopenic purpura.
    Cheung RT
    N Engl J Med; 2000 Oct; 343(16):1192; author reply 1193-4. PubMed ID: 11041755
    [No Abstract]   [Full Text] [Related]  

  • 20. Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting.
    Anselmino M; Moretti C; Ravera L; Sheiban I
    Minerva Cardioangiol; 2010 Apr; 58(2):277-80. PubMed ID: 20440256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.